Portland, OR, June 23, 2022 (GLOBE NEWSWIRE) — According to the report released by Allied Market Research, the Intravenous (IV) therapy and venous access Market generated $22.8 billion in 2020 and is expected to reach $37.5 billion by 2030, growing at a CAGR of 5.1% from 2021 to 2030. The report provides an in-depth analysis of major investment pockets, of the best winning strategies, drivers and opportunities, market size and estimations, competitive scenario and hesitant market trends.
Download a sample PDF at: https://www.alliedmarketresearch.com/request-sample/2350
A significant increase in cases of chronic diseases among people, growth in road accidents, increase in healthcare and health insurance expenditures, and increase in geriatric population across the world are expected to drive growth of the global intravenous (IV) therapy and venous access market. On the other hand, lack of experienced healthcare professionals is expected to hamper the market growth. However, the remarkable upsurge in critical care therapies is expected to create many opportunities for the industry.
COVID-19 scenario
- The COVID-19 outbreak has positively impacted the growth of the global intravenous (IV) therapy and venous access market, owing to the rapid increase in the spread of coronavirus among people across the world. IV therapy has been widely used in patients with acute respiratory distress syndrome (ARDS) associated with COVID-19.
- Thus, the increase in the number of patients suffering from ARDS associated with COVID-19 has subsequently increased the demand for intravenous (IV) therapy and venous access.
The report offers a detailed segmentation of the global intravenous (IV) therapy and venous access market based on type, medical application, end-user, and region.
Specific requirement on COVID-19? Ask our industry expert: https://www.alliedmarketresearch.com/purchase-enquiry/2350
Based on applications, the drug delivery segment held the largest market share in 2020, grabbing more than a third of the global market. Furthermore, the same segment is expected to quote the fastest CAGR of 5.6% during the forecast period. Other segments analyzed in the report include Volume Expanders, Blood Products & Nutrition, and Buffer Solution.
On the basis of end-user, the hospital segment held the majority of market share in 2020, holding nearly half of the global market. The clinics segment, on the other hand, is expected to feature the Fastest CAGR of 7.0% during the forecast period.
Depending on the region, the North American market took the lion’s share in 2020, taking around two-fifths of the global market. The Asia-Pacific region, on the other hand, is expected to quote the fastest CAGR of 6.4% during the forecast period.
Key players analyzed in the global Intravenous (IV) Therapy and Venous Access market report are Becton, Dickinson & Company, Braun Melsungen AG, Terumo medical corporation, Teleflex Medical Inc., Medtronic Inc., Angiodynamic, Inc., Smith & Nephew Plc. ., Pfizer Inc., Insulet Corporation and Fresenius SE& CO. KGAA.
| Report attribute | Details |
| Revenue forecasts in 2030 | $37.5 billion |
| Rate of growth | CAGR of 5.1% from 2021 to 2030 |
| Forecast period | 2022 – 2030 |
| Report cover | Revenue Forecast, Business Ranking, Competitive Landscape, Growth Factors and Trends |
| Regional scope | North America, Europe, Asia-Pacific, Latin America, MEA |
| Country scope | United States, Canada, Germany, United Kingdom, France, Italy, Spain, Japan, China, India, South Korea, Australia, Brazil, Mexico, South Africa, Saudi Arabia |
| Profiled Key Companies | Becton, Dickinson & Company, Braun Melsungen AG, Terumo medical corporation, Teleflex Medical Inc., Medtronic Inc., Angiodynamic, Inc., Smith& Nephew Plc., Pfizer Inc., Insulet Corporation and Fresenius SE& CO. KGAA. |
Avenue Basic Plan | Access to the library | 1 year subscription |
Sign up for the Avenue subscription to access over 12,000 business profiles and over 2,000 niche market research reports for $699 per month, per post. For one year, the customer must purchase a minimum 2-seat plan.
14-day free trial request: https://www.alliedmarketresearch.com/avenue/trial/starter
“We have also published some syndicated market studies in the same field that you may be interested in. Below is the title of the report for your referenceconsidering the impact of Covid-19 on this market which will help you to assess the aftereffects of the pandemic on the short and long term growth trends of this market.
Reports on trends in the healthcare industry (book now with 10% discount):
Micromanipulators Market – Global Opportunity Analysis and Industry Forecast, 2020-2028
Biomaterials Market – Global Opportunity Analysis and Industry Forecast, 2020-2028
Point-of-Care Diagnostics Market – Global Opportunity Analysis and Industry Forecast, 2020-2028
Ostomy Drainage Bags Market – Global Opportunity Analysis and Industry Forecast, 2020-2028
Electrophysiology Market – Global Opportunity Analysis and Industry Forecast, 2020-2028
Surgical Microscopes Market – Global Opportunity Analysis and Industry Forecast, 2020-2028
MRI System Market – Global Opportunity Analysis and Industry Forecast, 2020-2028
Biosurgery Market – Global Opportunity Analysis and Industry Forecast, 2020-2028
Analgesics Market – Global Opportunity Analysis and Industry Forecast, 2020-2028
Medical/Diagnostic Imaging Market – Global Opportunity Analysis and Industry Forecast, 2020-2028
About Us
Allied Market Research (AMR) is a full-service market research and business consulting division of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global corporations as well as small and medium enterprises with unrivaled quality of “market research reports” and “Business Intelligence solutions”. AMR has a focused vision to provide business insights and advice to help its clients make strategic business decisions and achieve sustainable growth in their respective market area.
Pawan Kumar, CEO of Allied Market Research, directs the organization towards the provision of high quality data and information. We maintain professional relationships with various companies which helps us to extract market data which helps us to generate accurate research data tables and confirm the utmost accuracy of our market predictions. All data presented in the reports we publish are drawn from primary interviews with senior managers of large companies in the relevant field. Our secondary data sourcing methodology includes extensive online and offline research and discussions with knowledgeable industry professionals and analysts.
